안녕하세요. 금일 체결한 노바티스 라이선스 계약에 대해 해외 배포한 영문기사 공유드립니다.
https://finance.yahoo.com/healthcare/articles/alteogen-enters-option-license-agreement-110000294.html
Yahoo Finance
Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous…
Alteogen Inc. (KOSDAQ: 196170), a leading biopharmaceutical company specializing in platform technologies, announced today that it has entered into an option and license agreement with Novartis for the development and commercialization of subcutaneous (SC)…
62
29
6
5
5
3
1
1September 2, 2026 5.6K 33
